Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Nausea × Palonosetron × Plasma cell × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 3 Breast 3 Other hematologic neoplasm 2 Head & Neck 2 Gastrointestinal 2 Thoracic 1 Sarcoma 1 Plasma cell 1 Dermatologic 1

Conditions

Multiple Myeloma 2 Neoplasms 1 Nausea 1 Lymphoma 1

Interventions

Aprepitant 5 Dexamethasone 4 Ondansetron 3 Calcium Dobesilate 3 Olanzapine 2 isatuximab 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 Sugars 1 Palonosetron 1 Music Therapy 1 Immunoenzyme Techniques 1 Granisetron 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00600353 2017-03-09

Multi-day Doses in Prevention of Nausea and Emesis

University of Kansas Medical Center

Phase 2 Completed

20 enrolled 8 charts

LymphoidPlasma cell

Lymphoma, Multiple Myeloma, Nausea, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡